Mallevais M L, Delacourte A, Lesieur I, Lesieur D, Cazin M, Brunet C, Luyckx M
Biochimie. 1984 Jun;66(6):477-82. doi: 10.1016/0300-9084(84)90083-x.
With the relation between chemical structure and pharmacological activity as a guide, we have been for some time synthetizing a wide range of beta-amino-ketone derivatives. One of them, 2-(4-methyl-1-piperazinylmethyl) acrylophenone, MPMAP, possesses antimicrotubular activities. This product inhibits 50% of the microtubule polymerization at a 3.10(-5) M concentration. It does not prevent tubulin paracrystal formation induced by vinblastine, and binding experiments reveal that this product is a weak inhibitor of colchicine binding. The structure of this compound is different from the other antimicrotubular agents and has the advantage of being far less complex, highly soluble and easy to synthesize. Thus, this product and related compounds should be a new tool for the study of antimicrotubular activities and tubulin assembly.
以化学结构与药理活性之间的关系为指导,我们一段时间以来一直在合成多种β-氨基酮衍生物。其中之一,2-(4-甲基-1-哌嗪基甲基)苯丙烯酮(MPMAP)具有抗微管活性。该产品在3.10(-5) M浓度下可抑制50%的微管聚合。它不能阻止长春碱诱导的微管蛋白副晶形成,结合实验表明该产品是秋水仙碱结合的弱抑制剂。该化合物的结构与其他抗微管剂不同,具有远不那么复杂、高度可溶且易于合成的优点。因此,该产品及相关化合物应成为研究抗微管活性和微管蛋白组装的新工具。